{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:04:05Z","timestamp":1772463845608,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.biopsych.2012.04.032","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T16:03:03Z","timestamp":1339516983000},"page":"700-706","source":"Crossref","is-referenced-by-count":46,"title":["Brain-Derived Neurotrophic Factor Levels and Its Val66Met Gene Polymorphism Predict Tardive Dyskinesia Treatment Response to Ginkgo Biloba"],"prefix":"10.1016","volume":"72","author":[{"given":"Xiang Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Hong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Ran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin N.","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese A.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.04.032_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","article-title":"Tardive dyskinesia and new antipsychotics","volume":"21","author":"Correll","year":"2008","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/YCO.0b013e328017f6b1","article-title":"Tardive dyskinesia: Eliminated, forgotten, or overshadowed?","volume":"20","author":"Remington","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2012.04.032_bib4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen radicals and neuropsychiatric illness","volume":"48","author":"Lohr","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib5","first-page":"159","article-title":"Free radical involvement in neuropsychiatric illnesses","volume":"31","author":"Lohr","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2012.04.032_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.04.032_bib7","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1097\/00001756-199808240-00030","article-title":"Medial nigral dopamine neurons have rich neurotrophin support in humans","volume":"9","author":"Nishio","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2012.04.032_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0006-8993(94)91857-0","article-title":"NT-3 and BDNF protect CNS neurons against metabolic\/excitotoxic insults","volume":"640","author":"Cheng","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.04.032_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers for glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia","volume":"155","author":"Tsai","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2004.08.004","article-title":"Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements","volume":"74","author":"Tan","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.04.032_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2012.04.032_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.pnpbp.2008.05.016","article-title":"No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients","volume":"32","author":"Kang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.euroneuro.2009.01.001","article-title":"Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia","volume":"19","author":"Zai","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2012.04.032_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0002-9343(00)00290-4","article-title":"Ginkgo biloba: A living fossil","volume":"108","author":"Jacobs","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.biopsych.2012.04.032_bib15","series-title":"Ginkgo Biloba Extract (EGb): Pharmacological Activities and Clinical Applications","first-page":"61","article-title":"In vivo studies with EGb 761","author":"Defeudis","year":"1991"},{"key":"10.1016\/j.biopsych.2012.04.032_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0301-0082(02)00015-1","article-title":"The CNS effects of Ginkgo biloba extracts and ginkgolide B","volume":"67","author":"Maclennan","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2012.04.032_bib17","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/1381612054065729","article-title":"Oxidative stress, antioxidants and neurodegenerative diseases","volume":"11","author":"Casetta","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2012.04.032_bib18","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1073\/pnas.111126298","article-title":"The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba","volume":"98","author":"Watanabe","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.04.032_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(00)03131-0","article-title":"The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands","volume":"889","author":"Yao","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2012.04.032_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1043-6618(02)00233-5","article-title":"Bilobalide and neuroprotection","volume":"46","author":"Defeudis","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.biopsych.2012.04.032_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.182425199","article-title":"Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761","volume":"99","author":"Luo","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.04.032_bib22","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1096\/fj.06-7649com","article-title":"EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease","volume":"21","author":"Tchantchou","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.biopsych.2012.04.032_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-2009-1189","article-title":"Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons","volume":"18","author":"Tchantchou","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2012.04.032_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4088\/JCP.09m05125yel","article-title":"Extract of ginkgo biloba treatment for tardive dyskinesia in schizophrenia: A randomized, double-blind, placebo-controlled trial","volume":"72","author":"Zhang","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib25","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID I\/P, version 2.0)","author":"First","year":"1995"},{"key":"10.1016\/j.biopsych.2012.04.032_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib27","series-title":"Ginkgo Biloba Extract (EGb761): Pharmacological Activities and Clinical Applications","first-page":"1","article-title":"Introduction","author":"DeFeudis","year":"1991"},{"key":"10.1016\/j.biopsych.2012.04.032_bib28","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.pnpbp.2009.08.011","article-title":"Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics","volume":"33","author":"Xiu","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/342288","article-title":"The brain derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study","volume":"71","author":"Neves-Pereira","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2012.04.032_bib30","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/sj.npp.1301619","article-title":"BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia","volume":"33","author":"Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.04.032_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archpsyc.58.11.1049","article-title":"Melatonin treatment for tardive dyskinesia: A double-blind, placebo-controlled, crossover study","volume":"58","author":"Shamir","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4088\/JCP.v68n0309","article-title":"Treatment of tardive dyskinesia with galantamine: A randomized controlled crossover trial","volume":"68","author":"Caroff","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/jcbfm.1994.86","article-title":"Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus","volume":"14","author":"Beck","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2012.04.032_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1989.tb14918.x","article-title":"Possible involvement of free radicals in neuroleptic-induced movement disorders","volume":"570","author":"Cadet","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2012.04.032_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hup.412","article-title":"A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: Neuropsychological findings","volume":"17","author":"Mix","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.04.032_bib37","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1468-1331.2006.01409.x","article-title":"Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study","volume":"13","author":"Mazza","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.biopsych.2012.04.032_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13607860902749057","article-title":"Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial","volume":"13","author":"Yancheva","year":"2009","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.biopsych.2012.04.032_bib39","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1111\/j.1460-9568.2007.05905.x","article-title":"Restoration of impaired phosphorylation of cyclic AMP response element-binding protein (CREB) by EGb 761 and its constituents in Abeta-expressing neuroblastoma cells","volume":"26","author":"Xu","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2012.04.032_bib40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cellbi.2005.12.012","article-title":"Effects of ginkgolide on the development of NOS and AChE positive neurons in the embryonic basal forebrain","volume":"30","author":"Jin","year":"2006","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.biopsych.2012.04.032_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004714-200102000-00015","article-title":"The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia","volume":"21","author":"Zhang","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.04.032_bib42","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4088\/JCP.v62n1107","article-title":"A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia","volume":"62","author":"Zhang","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.04.032_bib43","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","article-title":"Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J Neurosci"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312004180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312004180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T16:55:11Z","timestamp":1542905711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312004180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0006322312004180"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.04.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717950012.793455215","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717950012.793455806","asserted-by":"object"}]},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}